MiCheck Trial

Our industry partner,  Minomic has launched a US study of their MiCheck® Prostate Cancer Test.  This important trial will further verify MiCheck’s accuracy and reliability in detecting prostate cancer, especially for identifying patients with clinically significant cancer. See News for more details. The IDEAL Research Hub members visited the Minomic lab based at Macquarie University in Sydney and members will spend times based in their labs later this year.